Literature DB >> 6294140

Beta endorphin selectively stimulates aldosterone secretion in hypophysectomized, nephrectomized dogs.

H G Güllner, J R Gill.   

Abstract

We examined the effects of synthetic human beta-endorphin (beta END) and a stable methionine (Met)-enkephalin analogue on aldosterone and cortisol secretion rates in anesthetized, hypophysectomized, and nephrectomized dogs and compared them to those of (1-39) ACTH. The circulation of the adrenal glands was completely isolated on the arterial and venous sides (Hilton Pouch). The peptides were infused to deliver 3 pmol/min into the aortic "pouch." Blood was collected from the vena caval pouch, which received blood only from the adrenal gland. Secretion rates of aldosterone and cortisol were calculated as the product of adrenal blood flow and venous steroid concentration. Duplicate steroid measurements were obtained during a control period, at 10, 30, and 50 min of peptide infusion and during a postcontrol period. BetaEND increased aldosterone secretion rate from 2.4 +/- 0.5 ng/min (mean +/- SEM) to 3.2 +/- 0.9 ng/ min at 10 min (N.S.), 8.2 +/- 2.5 ng/min (P less than 0.05) at 30 min and 11.0 +/- 3.7 ng/ min (P less than 0.05) at 50 min of infusion. Cortisol secretion rate was not affected by infusion of betaEND. Infusion of the stable Met-enkephalin analogue D-alanine2; Metphenylalanine4, Met(O)-enkephalin-ol or saline alone had no effect on aldosterone or cortisol secretion rates. ACTH infusion increased mean aldosterone secretion rate by approximately 215% and significantly stimulated cortisol secretion rate. These results indicate that beta END selectively stimulates aldosterone secretion with a potency similar to that of an equimolar dose of ACTH.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6294140      PMCID: PMC436844          DOI: 10.1172/jci110740

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  Parallel radioimmunoassay for plasma cortisol and 11-deoxycortisol.

Authors:  M Kao; S Voina; A Nichols; R Horton
Journal:  Clin Chem       Date:  1975-10       Impact factor: 8.327

2.  Isolation, primary structure, and synthesis of alpha-endorphin and gamma-endorphin, two peptides of hypothalamic-hypophysial origin with morphinomimetic activity.

Authors:  N Ling; R Burgus; R Guillemin
Journal:  Proc Natl Acad Sci U S A       Date:  1976-11       Impact factor: 11.205

3.  C fragment of lipotropin has a high affinity for brain opiate receptors.

Authors:  N J Birdsall; E C Hulme
Journal:  Nature       Date:  1976-04-29       Impact factor: 49.962

4.  Primary aldosteronism. A study in contrasts.

Authors:  M G Nicholls; E A Espiner; H Hughes; J Ross; D T Stewart
Journal:  Am J Med       Date:  1975-09       Impact factor: 4.965

5.  A synthetic enkephalin analogue with prolonged parenteral and oral analgesic activity.

Authors:  D Roemer; H H Buescher; R C Hill; J Pless; W Bauer; F Cardinaux; A Closse; D Hauser; R Huguenin
Journal:  Nature       Date:  1977-08-11       Impact factor: 49.962

6.  A reappraisal of human beta MSH.

Authors:  G A Bloomfield; A P Scott; P J Lowry; J J Gilkes; L H Rees
Journal:  Nature       Date:  1974-12-06       Impact factor: 49.962

7.  Isolation of a hypertension-producing compound from normal human urine.

Authors:  S Sen; E L Bravo; F M Bumpus
Journal:  Circ Res       Date:  1977-05       Impact factor: 17.367

8.  Development and validation of a radioimmunoassay for peptides related to beta-melanocyte-stimulating hormone in human plasma: the lipotropins.

Authors:  J J Gilkes; G A Bloomfield; A P Scott; P J Lowry; J G Ratcliffe; J Landon; L H Rees
Journal:  J Clin Endocrinol Metab       Date:  1975-03       Impact factor: 5.958

9.  Identification of two related pentapeptides from the brain with potent opiate agonist activity.

Authors:  J Hughes; T W Smith; H W Kosterlitz; L A Fothergill; B A Morgan; H R Morris
Journal:  Nature       Date:  1975-12-18       Impact factor: 49.962

10.  Substantial rise of plasma beta-endorphin levels after insulin-induced hypoglycemia in human subjects.

Authors:  K Nakao; Y Nakai; H Jingami; S Oki; J Fukata; H Imura
Journal:  J Clin Endocrinol Metab       Date:  1979-12       Impact factor: 5.958

View more
  3 in total

1.  Plasma immunoreactive gamma melanotropin in patients with idiopathic hyperaldosteronism, aldosterone-producing adenomas, and essential hypertension.

Authors:  G T Griffing; B Berelowitz; M Hudson; R Salzman; J A Manson; S Aurrechia; J C Melby; R C Pedersen; A C Brownie
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

2.  Central serotonergic stimulation of aldosterone secretion.

Authors:  Y Shenker; M D Gross; R J Grekin
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

3.  Beta endorphin release in patients after spontaneous and provoked acute myocardial ischaemia.

Authors:  K G Oldroyd; K Harvey; C E Gray; G H Beastall; S M Cobbe
Journal:  Br Heart J       Date:  1992-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.